Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis...

Area of Science:

• Psychiatry and Neuroscience
• Clinical Psychology
• Pharmacogenetics

Background:

• First episode psychosis (FEP) requires thorough characterization to understand underlying mechanisms.
• Identifying predictors of clinical and neurobiological outcomes is crucial for effective FEP management.
• The interplay between genetic and environmental factors in FEP is not fully elucidated.

Purpose of the Study:

• To conduct a comprehensive clinical and neurocognitive assessment of patients experiencing their first episode of psychosis.
• To investigate interactions between genetic and environmental variables in predicting clinical and brain structural outcomes.
• To explore the relationship between genetic polymorphisms and treatment response, including adverse effects.

Main Methods:

• A multicenter, naturalistic, prospective, longitudinal study design.
• Inclusion of nearly 350 FEP patients and 250 healthy controls.
• Assessment of clinical, neuropsychological, neuroimaging, biochemical, environmental, and pharmacogenetic variables.

Main Results:

• Detailed clinical and neurocognitive profiles of FEP patients were established.
• Data collection facilitated the examination of gene-environment interactions.
• Pharmacogenetic data were gathered to analyze treatment response and side effects.

Conclusions:

• The PEPs study provides a rich dataset for understanding FEP.
• Findings contribute to identifying predictive markers for clinical and brain outcomes in psychosis.
• The study enhances knowledge of pharmacogenetics in FEP treatment.